XML 39 R30.htm IDEA: XBRL DOCUMENT v3.25.1

Note 1 - Nature of the Business and the Basis of Preparation (Details Textual) - USD ($)			1 Months Ended
	Feb. 19, 2025	Jan. 24, 2025	Jan. 31, 2025	Mar. 31, 2025
SEED Therapeutics Inc. [Member]
Ownership Percentage in Subsidiaries			14.37%	37.56%
Seed [Member]
Ownership Percentage in Subsidiaries				40.12%
Seed [Member]
Proceeds from Sale, Maturity and Collection of Investments	$ 7,354,000	$ 35,418	$ 35,418,000

X

- Definition

Represents the percentage of ownership in subsidiaries.

+ References

No definition available.

+ Details

Name:	bysi_OwnershipPercentageInSubsidiaries
Namespace Prefix:	bysi_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-12

+ Details

Name:	us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	srt_OwnershipAxis=bysi_SEEDTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=bysi_SeedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=bysi_SeedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: